Your browser doesn't support javascript.
loading
Protective Effects of ß-Blockers on Bone in Older Adults with Dementia.
Khuc, Khiem; des Bordes, Jude; Ogunwale, Abayomi; Madel, Maria-Bernadette; Ambrose, Catherine; Schulz, Paul; Elefteriou, Florent; Schwartz, Ann; Rianon, Nahid J.
Afiliación
  • Khuc K; Department Family and Community Medicine, UTHealth McGovern Medical School, Houston, TX, USA.
  • des Bordes J; Department Family and Community Medicine, UTHealth McGovern Medical School, Houston, TX, USA.
  • Ogunwale A; Department Family and Community Medicine, UTHealth McGovern Medical School, Houston, TX, USA.
  • Madel MB; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Ambrose C; Department of Orthopedic Surgery, UTHealth McGovern Medical School, Houston, TX, USA.
  • Schulz P; Department of Neurology, UTHealth McGovern Medical School, Houston, TX, USA.
  • Elefteriou F; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Schwartz A; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
  • Rianon NJ; Department Family and Community Medicine, UTHealth McGovern Medical School, Houston, TX, USA. Nahid.J.Rianon@uth.tmc.edu.
Calcif Tissue Int ; 115(1): 14-22, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38744723
ABSTRACT
Increased ß-adrenergic receptor activity has been hypothesized to cause bone loss in those with dementia. We investigated the effect of long-term ß-blocker use on rate of bone loss in older adults with dementia. We used a linear mixed-effects model to estimate the relationship between long-term ß-blocker use and rate of bone loss in participants from the Health Aging and Body Composition study. Records of 1198 participants were analyzed, 44.7% were men. Among the men, 25.2% had dementia and 20.2% were on ß-blockers, while in the women, 22.5% had dementia and 16.6% received ß-blockers. In the 135 men with dementia, 23 were taking ß-blockers, while 15 of 149 women with dementia were using ß-blockers. In men with dementia, ß-blocker users had 0.00491 g/cm2 less bone mineral density (BMD) loss per year at the femoral neck (i.e., 0.63% less loss per year) than non-users (p < 0.05). No differences were detected in women with or without dementia and men without dementia. ß-blockers may be protective by slowing down bone loss in older men with dementia.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Densidad Ósea / Antagonistas Adrenérgicos beta / Demencia Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Calcif Tissue Int Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Densidad Ósea / Antagonistas Adrenérgicos beta / Demencia Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Calcif Tissue Int Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos